Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...

Samsara is the IBD Stock of the Day ahead of its Q4 earnings report due March 6. Samara stock has forged a cup base, rebounding from a sell-off.

A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...

The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...

The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease ...

Brady Cl A saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 72. Please watch the ...

In terms of fundamentals, Omnicell has posted three quarters of increasing earnings growth. Revenue growth has also moved ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...